Secteur Carisma Therapeutics, Inc.

Actions

CARM

US14216R1014

Recherche biotechnologique et médicale

Marché Fermé - OTC Markets 21:48:19 20/07/2026 Varia. 5j. Varia. 1 janv.
0,004200 USD -19,23% Graphique intraday de Carisma Therapeutics, Inc. -5,45% -87,91%
Principaux concurrents
Varia. Varia. 5j. Variation 1 mois Variation 3 mois Varia. 1 janv. Varia. 1an Varia. 3ans Varia. 5ans Varia. 10ans Capi.($)
-19,23%-5,45%-72,63%-83,23%-87,91%-98,67%-99,94% - - 218 k
+0,21%-1,34%-2,61%+4,99%+5,13%+53,17%+60,65%+185,13%+5 696,92% 53,83 Md
+5,37%+0,75%+20,93%+24,98%+37,05%+50,39%+83,03%-25,99% - 52,1 Md
-1,20%-0,62%+10,00%-24,05%-37,68%+5,53%+409,46%+309,61%+877,16% 23,48 Md
+0,74%+2,20%+2,06%-12,49%-3,31%-15,48%-14,55%-62,45% - 23,13 Md
+3,46%+0,79%+24,14%+7,11%+21,69%+34,01%-4,47%-72,59% - 19,36 Md
-1,18%-1,15%+12,86%+2,38%-8,88%+30,12%-32,02%-32,10%+59,22% 17,56 Md
-1,67%-8,56%+22,96%+99,60%+177,32%+163,95%+284,69%+1 543,66%+625,02% 15,2 Md
+3,62%-2,42%+21,21%-3,08%+28,51%+29,70%+663,64% - - 14,83 Md
-0,70%+0,36%+9,52%+28,96%+28,31%+27,07%+183,04%+233,18%+559,32% 14,06 Md
-3,21%+0,95%+4,51%+1,69%-7,95%+61,97%+151,44%+475,26% - 12,76 Md
-1,33%-2,52%+1,26%+21,21%+26,16%+116,90%+147,42%+174,73%+723,05% 10,89 Md
-2,24%-10,03%-3,61%-45,20%-21,30%-47,74%+540,23%+82,80%+93,44% 10,72 Md
-3,57%-2,14%-11,55%+4,73%+9,24%+393,03%+108,29%+6,80%+1 165,71% 10,47 Md
+5,66%-4,01%+6,62%-38,18%-17,39%-33,65%+160,03%+62,91% - 10,38 Md
+0,02%+0,05%+0,43%+15,19%+23,23%+48,63%+178,44% - - 9,83 Md
+0,01%+0,25%+137,07%+108,39%+80,18%+171,00%+319,38%+317,50% - 8,84 Md
-2,89%+6,16%-0,82%+35,58%+203,72%+508,56%+564,44%-42,40%-12,91% 8,81 Md
+0,74%-.--%-.--%-.--%-.--%-.--%+54,45%+110,19% - 8,19 Md
-1,25%-2,75%+6,43%-10,53%+20,20%+55,61%+15,88%+138,54% - 8,12 Md
Moyenne +0,08%-0,99%+9,44%+6,90%+23,82%+77,70%+188,68%+200,28%+1 087,44% 16,63 Md
Moyenne pondérée par Capi. +1,15%-0,89%+11,92%+10,61%+23,44%+66,15%+166,02%+172,95%+2 221,89%
Médicaments bio-thérapeutiques
  1. Bourse
  2. Actions
  3. Action CARM
  4. Secteur Carisma Therapeutics, Inc.